Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01342523 · ClinicalTrials.gov registry record · Phase 4
Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,034
- Enrollment target
NCT01342523: Completed Phase 4 study, sponsored by University of Wisconsin, Madison.
NCT01342523 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 1,034 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01342523, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,034 participants
- Enrollment target
Study Summary
This is an evaluative study of three National Cancer Institute (NCI) smoking cessation resources: specifically, the smokefree.gov and women smokefree.gov websites, and the CIS counseling phone calls. The following are the identified critical questions: (1). How effective is each of the tobacco interventions (websites \[smokefree.gov \& women smokefree.gov\], NCI's Cessation Quitline counseling services operated by the Cancer Information Service (CIS) (2). How do they compare with alternative intervention strategies? (3). Which types of interventions appear to work best together (due to additive or interactive effects)? (4). How do these interventions work? (5). How much are these interventions used, and what are their relative use rates? (6). Are there important differences in effectiveness or use rates as a function of gender, SES, or other important person factors? We believe that the research study will address all of these questions, as well as some less central ones.
Primary Outcome
Abstinence will be defined as 7-day point prevalence.
Interventions
- OTHER CIS - telephone cessation quitline counseling
- OTHER Lozenge - nicotine mini-lozenges
- OTHER Emails - Brief smoking prevention messages
- OTHER Full website - standard smokefree.gov website content
- OTHER Lite website - lite version of smokefree.gov
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,034 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-10 |
| Phase | Phase 4 |
What the finished NCT01342523 record still lists
NCT01342523 is an interventional study that assigns participants to a tested intervention. Its 1,034 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% higher).
The record links to 0 conditions, and to 5 interventions - of which CIS - telephone cessation quitline counseling is the first listed.
NCT01342523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01342523 about?
NCT01342523 is a clinical study titled "Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources". This is an evaluative study of three National Cancer Institute (NCI) smoking cessation resources: specifically, the smokefree.gov and women smokefree.gov websites, and the CIS counseling phone calls. The following are the identified critical questions: (1). How effective is each of the tobacco inter...
What is the current status of trial NCT01342523?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,034 participants. The study started on 2011-10. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01342523?
The interventions under investigation include: CIS - telephone cessation quitline counseling (OTHER), Lozenge - nicotine mini-lozenges (OTHER), Emails - Brief smoking prevention messages (OTHER), Full website - standard smokefree.gov website content (OTHER), Lite website - lite version of smokefree.gov (OTHER).
Who is sponsoring clinical trial NCT01342523?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01342523's enrollment target sits among peer trials
1,034 66th of 2000 higher than 1,935 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05037682 · 1,035 participants · NA
Pain and Opioid Management in Older Adults
- NCT07282600 · 1,035 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NCT07084363 · 1,032 participants · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
- NCT07345767 · 1,038 participants · NA
Hypknowledge Nationwide Sleep Extension
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia